Clinical trials
Phase 4 Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 5 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bispebjerg Hospital | 1 |
| DARTNet Institute | 1 |
| Fondazione Telethon | 1 |
| Grifols Therapeutics LLC | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Medical Research Council | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Peking Union Medical College Hospital | 1 |
| Swiss Pediatric Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 14 |
| Asthma | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Autoimmune Diseases | 2 |
| Bronchial Diseases | 2 |
| HIV Infections | 2 |
| Immunoproliferative Disorders | 2 |
| Lung Diseases | 2 |
| Lung Diseases, Obstructive | 2 |
| Respiratory Hypersensitivity | 2 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.